NASDAQ · LSBPW
LakeShore Biopharma Co., Ltd.
Healthcare · Biotechnology
$0.01
Up+$0.00 (+0.00%)
Updated Sep 18, 2026, 7:05 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 307.88K
- P/E ratio
- -6.19
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 772.86K
- Avg. volume
- 37.81K
Price performance
LSBPW price history
1M range · 0 trading sessions · Daily adjusted prices
LSBPW does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest LSBPW news
The latest Smart Investors Daily articles mentioning LSBPW.
Stock researchCompany · Overview
LSBPW research
Overview
Company profile and research snapshot.
Company profile
LakeShore Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
